Patents Assigned to AMD THERAPEUTICS LLC
  • Ophthalmic compositions of rifamycins and uses thereof
    Patent number: 11850213
    Abstract: Provided herein are ophthalmic pharmaceutical formulations comprising a rifamycin compound. Also provided herein are methods of treating ocular diseases or disorders by administering such ophthalmic formulations.
    Type: Grant
    Filed: November 13, 2020
    Date of Patent: December 26, 2023
    Assignee: AMD THERAPEUTICS LLC
    Inventor: Hiroaki Serizawa
  • TREATMENT OF SKIN DISORDERS BY TOPICAL ADMINISTRATION OF VEGF INHIBITORS
    Publication number: 20210145826
    Abstract: Topical administration of VEGF inhibitors such as, without limitation, rifamycin compounds are useful for treating skin disorders such as treating and/or reducing scars such as hypertrophic scars, and useful for treating acne and underlying acne symptoms such as skin redness.
    Type: Application
    Filed: June 25, 2020
    Publication date: May 20, 2021
    Applicant: AMD THERAPEUTICS LLC
    Inventor: Hiroaki Serizawa
  • Treatment of skin disorders by topical administration of VEGF inhibitors
    Patent number: 10709702
    Abstract: Topical administration of VEGF inhibitors such as, without limitation, rifamycin compounds are useful for treating skin disorders such as treating and/or reducing scars such as hypertrophic scars, and useful for treating acne and underlying acne symptoms such as skin redness.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: July 14, 2020
    Assignee: AMD THERAPEUTICS LLC
    Inventor: Hiroaki Serizawa
  • TREATMENT OF SKIN DISORDERS BY TOPICAL ADMINISTRATION OF VEGF INHIBITORS
    Publication number: 20180289701
    Abstract: Topical administration of VEGF inhibitors such as, without limitation, rifamycin compounds are useful for treating skin disorders such as treating and/or reducing scars such as hypertrophic scars, and useful for treating acne and underlying acne symptoms such as skin redness.
    Type: Application
    Filed: October 7, 2016
    Publication date: October 11, 2018
    Applicant: AMD THERAPEUTICS LLC
    Inventor: Hiroaki SERIZAWA